Search for: "More v. Johnson" Results 421 - 440 of 5,581
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Nov 2013, 11:24 pm by Jon Gelman
On Monday, Johnson & Johnson announced that it would be paying more than $2.2 billion to resolve civil and criminal claims relating to allegations that the company marketed Risperdal, a drug primarily designed to treat bi-polar disorder and schizophrenia, for uses other than those approved by the Food and Drug Administration. [read post]
24 Dec 2014, 11:50 am by Venkat Balasubramani
As we go down the path towards annoyance, the First Amendment challenge looks more and more meritorious. [read post]
19 Dec 2016, 7:29 am
Talc litigation is undoubtedly on the rise, as more and more people are becoming aware of the serious possible health implications of its use. [read post]
2 Apr 2012, 7:22 am by Eleanor Winslet
In the current economic environment, we are likely to see employers bringing more services back in-house to save costs, so similar scenarios to the Johnson Controls case are likely to arise more frequently. [read post]
1 Jul 2019, 8:09 am by Suzanne A. Luban
§ 924(c), applying the reasoning of two prior High Court cases on this topic, Johnson v. [read post]